The NIH Roadmap for Medical Research Funding provides a framework of the priorities NIH must address to optimize its research portfolio. It identifies the most compelling opportunities in three main areas: new pathways to discovery, research teams of the future, and re-engineering the clinical research enterprise. A newly released Roadmap funding opportunity is listed below. For information on additional Roadmap funding opportunities, go to http://nihroadmap.nih.gov.
Solicitation of Assays for High-Throughput Screening (HTS) in the Molecular Libraries Screening Centers Network (MLSCN)
PAR-05-147
Letter of Intent Receipt Dates: Aug. 16 and Dec. 21, 2005; Apr. 20, 2006
Application Receipt Dates: Sep. 14, 2005; Jan. 18 and May 18, 2006
This is a renewal of PAR-05-060. This funding opportunity will use the X01 award mechanism. The purpose of this announcement is to invite investigators to seek access for their HTS assays to the MLSCN, which intends to screen 100-200 HTS assays per year to fully utilize the capacity of the screening centers.
For more information, see http://cri.cancer.gov/4abst.cfm?initiativeparfa_id=3105.
Inquiries: Dr. Ingrid Li - ili1@mail.nih.gov
For comprehensive information about NCI funding priorities and opportunities, go to http://www.cancer.gov/researchandfunding.
|
